CLINICAL TRIALS PROFILE FOR MENOPUR
✉ Email this page to a colleague
All Clinical Trials for MENOPUR
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00257556 ↗ | A Study of the Efficacy and Safety of Highly Purified Menotrophin Versus Recombinant Follitropin Alfa | Completed | Ferring Pharmaceuticals | Phase 4 | 2005-10-01 | Prospective open label, randomised, parallel group, comparative pilot. |
NCT00335894 ↗ | Clinical Study of Clinical Efficacy and Tolerability of hMG-IBSA s.c.in Women Undergoing COH in an ART Programme (IVF). | Completed | IBSA Institut Biochimique SA | Phase 3 | 2005-05-01 | Multicenter, prospective, randomized, investigator blind, controlled clinical trial. Two parallel groups, one receiving the test drug hMG (hMG-IBSA, IBSA Institut Biochimique sa) and the other the reference drug hMG (Menopur, Ferring Pharmaceuticals, Inc.). |
NCT00492934 ↗ | What is the Best Preparation for Embryo Transfer in Cryo Cycles: a Natural Cycle or Light Hormonal Stimulation? | Unknown status | University Hospital, Gasthuisberg | N/A | 2004-01-01 | The study investigates if, among women with a regular cycle (between 25 and 45 days), the endometrium is better prepared for the transfer of an embryo that was cryopreserved and if the subsequent embryo implantation rate is higher when the cycle is started with daily, small-dose hormonal injections than in cycles without these daily injections. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for MENOPUR
Condition Name
Clinical Trial Locations for MENOPUR
Trials by Country
Clinical Trial Progress for MENOPUR
Clinical Trial Phase
Clinical Trial Sponsors for MENOPUR
Sponsor Name